










 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version
















Mark Griege











Mark C. Griege, J.D., CPA, CFPTreasurer






Mark Griege is a partner in the financial planning and 
  investment group of Robertson, Griege & Thoele. Mark is licensed as an 
  attorney, a Certified Public Accountant (CPA), and a CERTIFIED FINANCIAL 
  PLANNER Practitioner. 
  He graduated from Southern Methodist University with a Bachelor of Business 
  Administration degree, and from The University of Texas School of Law with a 
  Doctor of Jurisprudence degree.Mr. Griege serves on the editorial advisory board of the Journal of Financial 
  Planning. He has previously served on the national board of the Institute of 
  Certified Financial Planners in Denver, Colorado, having been a past president 
  of both the Dallas Chapter and Texas StateAssociation. He has also served as a member of the advisory board of Charles 
  Schwab & Co. Mark also serves as a member of the board of directors of The 
  Troy Aikman Foundation, an organization dedicated to meeting the needs of 
  underprivileged youth.* CFP and 
  CERTIFIED FINANCIAL PLANNER are certification marks owned by the Certified 
  Financial Planner Board of Standard, Inc. These marks are awarded to 
  individuals who successfully complete the CFP Boards initial and ongoing 
  certification requirements. 












<Close 

Window>



 


    Mark Griege | Robertson Griege & Thoele | ZoomInfo.com



Mark Griege











Mark C. Griege, J.D., CPA, CFPTreasurer






Mark Griege is a partner in the financial planning and 
  investment group of Robertson, Griege & Thoele. Mark is licensed as an 
  attorney, a Certified Public Accountant (CPA), and a CERTIFIED FINANCIAL 
  PLANNER Practitioner. 
  He graduated from Southern Methodist University with a Bachelor of Business 
  Administration degree, and from The University of Texas School of Law with a 
  Doctor of Jurisprudence degree.Mr. Griege serves on the editorial advisory board of the Journal of Financial 
  Planning. He has previously served on the national board of the Institute of 
  Certified Financial Planners in Denver, Colorado, having been a past president 
  of both the Dallas Chapter and Texas StateAssociation. He has also served as a member of the advisory board of Charles 
  Schwab & Co. Mark also serves as a member of the board of directors of The 
  Troy Aikman Foundation, an organization dedicated to meeting the needs of 
  underprivileged youth.* CFP and 
  CERTIFIED FINANCIAL PLANNER are certification marks owned by the Certified 
  Financial Planner Board of Standard, Inc. These marks are awarded to 
  individuals who successfully complete the CFP Boards initial and ongoing 
  certification requirements. 












<Close 

Window>



 





Insider Trading - Griege Mark C - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Griege Mark C





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-31Exercise
2017-01-047:41 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
37,496(Direct)
View


2016-12-31Exercise
2017-01-047:41 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
37,496(Direct)
View


2016-10-09Exercise
2016-10-124:34 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
88
$0
37,166(Direct)
View


2016-10-09Exercise
2016-10-124:34 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
88
$0
37,166(Direct)
View


2016-09-30Exercise
2016-10-033:46 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
37,078(Direct)
View


2016-09-30Exercise
2016-10-033:46 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
37,078(Direct)
View


2016-06-30Exercise
2016-07-011:04 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
36,748(Direct)
View


2016-06-30Exercise
2016-07-011:04 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
36,748(Direct)
View


2016-03-31Exercise
2016-04-0112:58 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
36,418(Direct)
View


2016-03-31Exercise
2016-04-0112:58 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
330
$0
36,418(Direct)
View


2016-01-01Option Award
2016-01-058:50 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
1,320
$0
1,320(Direct)
View


2015-10-09Exercise
2015-10-147:23 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
88
$0
36,088(Direct)
View


2015-10-09Exercise
2015-10-147:23 pm
N/AN/A
Veritex Holdings Inc.
VBTX
Griege Mark CDirector
88
$0
36,088(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 19:56:06 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  












Mark C. Griege | RGT Wealth Advisors
















































Client Login



 







Our TeamWe’re always strategic and we think outside the lines to bring our clients fresh ideas.
Our FocusRGT manages your finances so they don’t manage you. And that equates to complete peace of mind. 
Our ApproachWe’re an independent, fee-only firm that provides investment advice – always in our clients’ best interests.
Our LatestDid you know? RGT is always active and engaged, whether we’re making the news or sharing it.













 




Back to team page







email
mgriege@rgtadvisors.com





Mark C. Griege J.D.
Managing Director


Mark Griege is a founding partner of RGT*. During his impressive career, he has amassed more than 25 years of business, tax and investment experience. Before cofounding the firm, Mark was integrally involved in the tax departments at a “Big Five” accounting firm as well as a regional law firm.
Mark enjoys an active life in both the professional realm and the local community. He has previously chaired the national financial planning advisory council for the Financial Planning Association. He has served on both the editorial advisory board of the Journal of Financial Planning as well as the national board of the Institute of Certified Financial Planners. He is also active on the boards of several philanthropic foundations associated with the charitable efforts of his clients.
In terms of accolades, Mark was recognized by Worth Magazine as one of its “Best Financial Advisors” and has been previously named in D Magazine’s “Best Financial Planners in Dallas.” He frequently speaks on a variety of investment and financial planning topics.
Mark received his Bachelor of Business Administration from Southern Methodist University and his Doctor of Jurisprudence from the University of Texas School of Law. He was previously licensed both as an attorney and a Certified Public Accountant.
*This is not a CPA firm



email
mgriege@rgtadvisors.com



































 















Products Overview


























































WORLDWIDE 
            




Contact Us

Contact Us
FAQ
















Navigation
About Us


×
About Us

About Us
Corporate Responsibility
Reimbursement Support and Patient Assistance Programs

Leadership

– Board of Directors
– Executive Committee


Our Work

Our Work in Antimicrobial Resistance
Our Work in Hepatitis C
Our Work in Diabetes
Our Work in Oncology
Our Work in HIV
Our Work in Vaccines




How We Operate

– Code of Conduct

Our Values and Standards
Our Values and Standards For External Business Partners


– Compliance
– Privacy

– Transparency and Privacy
– Internet Privacy Policy
– Cookie Privacy Commitment
– Cross Border Policy
– Employment Privacy & Data Protection


– Diversity

– Employee Diversity
– Supplier Diversity
Programs and Partnerships
What We Buy
Definitions
Register Potential Supplier
Supplier Diversity






Views and Positions

– Access and Affordability
– Access to Investigational Medicines
– Innovation
– Quality and Safety
– Sales and Marketing
– Responsible Public Policy and Advocacy
Public Policy Position Statements
Trade Association Memberships


Our History

Company Fact Sheet


Our People
Featured Stories

Our Legacy - And Future - in American Manufacturing
Merck's IT Organization Expands into Austin, Texas
MECTIZAN Donation Is One for the Record Books
Journey for Control
A Point of View by Dr. Bao Lam
Fighting Some of the World's Toughest Bacterial Infections
Meet Dan Cua
It Takes a Village
Type 2 Diabetes: A Focus on A1C
May is for Mothers
Pushing to Outpace Superbugs
Merck Announces Enhancements to Family Leave Time
Classical Hodgkin Lymphoma: Facing Cancer in Young Adulthood
World Sleep Day
BeKindAlways4Noah
The Merck-Regenstrief Collaboration
Why Drug Discovery is the Foundation of Merck’s Future
How Chronic Hepatitis C is Impacting Our Veterans
Meet Gokul Swaminathan
Merck Honors Research Microbiologist H. Boyd Woodruff, Ph.D.
Merck Uses Amazon Web Services to Develop Voice-Enabled Solutions
Cancer Needs Cures. Still.
Merck Be Well Challenge 2016 — Bringing the Outside In
A Point of View by Adam Schechter, president of Global Human Health at Merck
Your Cancer Game Plan
Merck Foundation Grant Helps Expand Project ECHO
Merck’s Commitment to Prevention and Care for NCDs
Meet Jay Schiller
Merck Research Laboratories Expands into South San Francisco
Test. Talk. Take. Action.
Bridging the Gap in Diabetes Care
World Diabetes Day 2016
Meet Harriet Johnson
Merck Employees Surpass Goal of 125,000 Volunteer Hours
Merck for Mothers  Pep Talk
Meet Commander Adam Scott
Meet Noreen Rizvi
Ebola Outbreak
A Point of View by Dr. Roger Dansey
A Point of View by Dr. Gregory Lubiniecki
Merck’s Susan Shiff Selected
Faces of the Future
Merck Research Laboratories Honored
Living with Breast Cancer
Health Literacy
A Point of View by Julie Gerberding, M.D., M.P.H.
Meet Paige Cramer
Merck Releases 2015/2016 Corporate Responsibility Report
How Merck Animal Health Helped to Curb a New Strain of CIV
Women in Science
2016 Merck Fellowship for Global Health
Meet Daria Hazuda
A Point of View by Dr. Jonathan Cheng
Understanding Head and Neck Cancer
HPV Awareness
Meet Arnaub Chatterjee
Fasting and Diabetes
Understanding Diabetes
Living with Type 2 Diabetes
It's Personal Series
Collaborating to Cure
Meet Mike Thien
Roy Vagelos Honored by American Heart Association
Changing the Statistics
Charting a New Course in Cancer Care
New Approaches to Fighting Cancer
Melanoma... 'Never Walk Alone'
Be Safe In The Sun
America's Diabetes Challenge
World Immunization Week
Merck for Mothers at the Women in the World Summit
Vaccines: Our History, Our Legacy
The Impact of Cancer
Merck’s Commitment to Hepatitis C
Hepatitis C: A Silent Disease and Growing Concern
Using Water Wisely
Meet George W. Merck
Heart Disease
Guided by Research, Inspired by Hope
Why Animal Health Matters
Merck Turns 125
Cervical Health Awareness Month
Rallying to Meet the Need
William Campbell Wins Nobel Prize
Meet Christopher Kistler
Diversity and Inclusion: Good for Business
Understanding Alzheimer’s Disease
Living with HIV
Meet Jason Cheung
Hepatitis C: A Medical — and Social — Diagnosis
The Fight Against Hepatitis C
Saluting Those Who Serve
Lung Cancer: Challenges and Reasons for Hope
Real Innovation
World Diabetes Day
Lung Cancer
Refugee and Migrant Relief Efforts
What is C. difficile
Beyond Tired? So Are They...
Meet Alexander Buitrago Santanilla
Ken Frazier Receives Lifetime Achievement Award
Merck Employees Walk to End Alzheimer’s
Ken Frazier at the Clinton Global Initiative
Helping to Advance a New Set of UN Global Goals
Merck Fellowship for Global Health
2014 Corporate Responsibility Report
New Therapies to Attack Infections
The Race Against Resistance
Identifying the Next Generation of Antibacterial Therapies
The Fight Against Antimicrobial Resistance
Mectizan Donation Program
Meet Paul Reichert
Merck for Mothers at TEDWomen
Meet Spencer Dreher
Merck and HIV/AIDS
Fasting and Diabetes 
Merck's Rule the Real Talk Campaign
Meet Daisy Richardson
Art for All
MSD in Japan: Bringing Back the Beach 
A Commitment to Diabetes Research
A Silent Disease and Growing Concern
Meet Tim Cernak
Melanoma ... Never Walk Alone
Be Safe in the Sun
May is for Mothers
Bone Health Awareness
America's Diabetes Challenge
Pushing to Outpace Superbugs
The Evolution of Cancer Research
Parasites and Your Pets
Meet Ayesha Sitlani
Every Woman Every Child Event
Everyday Heroes
New Approaches to Fighting Cancer
Insomnia
Advancing Oncology Research Through Clinical Trials
Bridging the Gap  in Diabetes Care
Closing the Circle on Rabies
Desafiando la Diabetes
Understanding Diabetes
Helping Empower Women Living with HIV
Diabetes and Travel
Vaccines: Our History, Our Legacy
The Impact of Cancer
A Point of View by Eric Rubin, M.D.
Making a Difference






Inventing For Life


×
Inventing For Life

Inventing For Life






Products


×
Products

Products
Product List A-Z
Vaccines & Prescribing Information 
Prescription Products & Prescribing Information


Oncology Products & Prescribing Information

Animal Health


Product Patents
Authorized Distributors
Vaccine Contracted Distributors




Research


×
Research

Research
Our People, Our Culture

– The MRL Postdoctoral Research Fellow Program




Our R&D Process
What We're Working On
Pipeline


Clinical Trials
Invent with Us
Discover Where Our Research Happens




Licensing


×
Licensing

Business Development & Licensing


Incyte
Moderna
NGM Biopharmaceuticals



BD&L Contacts


News & Events






Newsroom


×
Newsroom

Newsroom
News Releases

– Prescription Medicine News
– Consumer Care News
– Vaccine News
– Research & Development News
– Corporate News
– Financial News
– Corporate Responsibility News
– Animal Health News





Information Centers


– Diabetes
– Ebola
– Hepatitis C
– Oncology


Company Statements

Media Center


Company Snapshot
Social Media






Careers


×
Careers

Careers
Apply Now
What’s Possible?

My Career Journey @Merck Anna Dickstein
My Career Journey @Merck Fran Murphy
My Career Journey @Merck Paige Cramer




Why Merck?


– Diversity At Merck
– From Service to Science
– Prepared for Launch
– Compensation and Benefits


How Will You Invent the Future?

My Career Journey @Merck Frank Clyburn







Canada
MSD Worldwide




Investors


×
Investors

Investors
Product Pipeline
News
Events & Presentations


Stock Info

– Stock Quote & Chart
– Historical Price Look-up
– Investment Calculator
– Dividend History
– Stock Splits
– Analyst Coverage


Financials

– Quarterly Reports
– Annual Reports & Proxy
– SEC Filings




Governance
Investor Resources

– FAQs
– Stockholder Services
– Corporate Responsibility
– Information Request
– Sign up for Email Alerts
– Other
– Contact Us
















Menu


MENU





















    							Improving Health Improving Lives
    						











                                With a steady focus on innovation and sound science, we work to deliver vaccines, medications, and consumer and animal health products that can help millions around the world.
                            











Today, Merck has more than 50 prescription products in various therapeutic areas, such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious diseases, immunology and women's health.
Visit Our Product List A - Z




LEARN MORE ABOUT OUR:



Prescription Products & Prescribing Information



Vaccines & Prescribing Information



Oncology Products & Prescribing Information










Need Help Paying forYour Medicine or Vaccines?
At Merck, we believe that no one should go without the medicines or vaccines they need.  Merck was among the first American pharmaceutical companies to offer assistance to those unable to afford their medications, through its patient assistance program started over 55 years ago.
Today, our MerckHelps program provides certain medicines and adult vaccines, for free, to eligible, underserved individuals across the nation.
Reimbursement support and patient assistance programs











For Health care professionals
Access tools and materials for patient support, product sample requests, up-to-date professional resources, and other Merck professional sites.
Health Care Professionals Website




Report Adverse Experience
To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080.










The Science ofHealthier Animals™










Merck Animal Health is a global leader in the research, development, manufacturing and sale of veterinary medicines, offering one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services.
Learn More











Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 



Forward-Looking Statement
Privacy
Terms of Use
Site Map







×Close
Forward-Looking Statement


Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA 
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
                
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. 
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). 
No Duty to Update  
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. 







































x
Worldwide


Merck





Canada
United States





MSD
Merck is known as MSD outside the United States and Canada. Clicking on any of the links below will take you to a website intended for those living outside the United States and Canada.






Algeria – French
Argentina – Spanish
Australia – English
Austria – German 
Belgium – Dutch, French, English
Brazil – Portuguese
Bulgaria – Bulgarian
Caribbean – English
Central America – Spanish
Chile – Spanish
China – Simplified Chinese
Colombia – Spanish
Costa Rica – Spanish
Croatia – Croatian
Czech Republic – Czech
Denmark – Danish
Dominican Republic – Dominican
Ecuador – Spanish
Egypt – English
Estonia – Estonian




Finland – Finnish
France – French
Fulford India – English
Germany – German
Greece – Greek
Hong Kong – Chinese, English
Hungary – Hungarian
India – English
Indonesia – English
Ireland – English
Italy – Italian
Japan – Japanese
Latvia – Latvian
Lithuania – Lithuanian
Malaysia – English
Mexico – Spanish
Montenegro – Serbian
Netherlands – Dutch
New Zealand – English
Norway – Norwegian




Peru – Spanish
Philippines – English
Poland – Polish
Portugal – Portuguese
Puerto Rico – Spanish, English
Romania – Romanian, English
Russia – Russian
Saudi Arabia – English
Serbia – Serbian
Singapore – English
Slovakia – Slovak
Slovenia – Slovene
South Africa  – English
South Korea – Korean
Spain – Spanish
Sweden – Swedish
Switzerland – English, French, German
Taiwan – Traditional Chinese
Thailand – Thai, English
Turkey – Turkish
Ukraine – Ukrainian
United Kingdom – English
Venezuela – Spanish
Vietnam – Vietnamese 








Close























































 














Merck.com | Products | Animal Health


























































WORLDWIDE 
            




Contact Us

Contact Us
FAQ
















Navigation
About Us


×
About Us

About Us
Corporate Responsibility
Reimbursement Support and Patient Assistance Programs

Leadership

– Board of Directors
– Executive Committee


Our Work

Our Work in Antimicrobial Resistance
Our Work in Hepatitis C
Our Work in Diabetes
Our Work in Oncology
Our Work in HIV
Our Work in Vaccines




How We Operate

– Code of Conduct

Our Values and Standards
Our Values and Standards For External Business Partners


– Compliance
– Privacy

– Transparency and Privacy
– Internet Privacy Policy
– Cookie Privacy Commitment
– Cross Border Policy
– Employment Privacy & Data Protection


– Diversity

– Employee Diversity
– Supplier Diversity
Programs and Partnerships
What We Buy
Definitions
Register Potential Supplier
Supplier Diversity






Views and Positions

– Access and Affordability
– Access to Investigational Medicines
– Innovation
– Quality and Safety
– Sales and Marketing
– Responsible Public Policy and Advocacy
Public Policy Position Statements
Trade Association Memberships


Our History

Company Fact Sheet


Our People
Featured Stories

Our Legacy - And Future - in American Manufacturing
Merck's IT Organization Expands into Austin, Texas
MECTIZAN Donation Is One for the Record Books
Journey for Control
A Point of View by Dr. Bao Lam
Fighting Some of the World's Toughest Bacterial Infections
Meet Dan Cua
It Takes a Village
Type 2 Diabetes: A Focus on A1C
May is for Mothers
Pushing to Outpace Superbugs
Merck Announces Enhancements to Family Leave Time
Classical Hodgkin Lymphoma: Facing Cancer in Young Adulthood
World Sleep Day
BeKindAlways4Noah
The Merck-Regenstrief Collaboration
Why Drug Discovery is the Foundation of Merck’s Future
How Chronic Hepatitis C is Impacting Our Veterans
Meet Gokul Swaminathan
Merck Honors Research Microbiologist H. Boyd Woodruff, Ph.D.
Merck Uses Amazon Web Services to Develop Voice-Enabled Solutions
Cancer Needs Cures. Still.
Merck Be Well Challenge 2016 — Bringing the Outside In
A Point of View by Adam Schechter, president of Global Human Health at Merck
Your Cancer Game Plan
Merck Foundation Grant Helps Expand Project ECHO
Merck’s Commitment to Prevention and Care for NCDs
Meet Jay Schiller
Merck Research Laboratories Expands into South San Francisco
Test. Talk. Take. Action.
Bridging the Gap in Diabetes Care
World Diabetes Day 2016
Meet Harriet Johnson
Merck Employees Surpass Goal of 125,000 Volunteer Hours
Merck for Mothers  Pep Talk
Meet Commander Adam Scott
Meet Noreen Rizvi
Ebola Outbreak
A Point of View by Dr. Roger Dansey
A Point of View by Dr. Gregory Lubiniecki
Merck’s Susan Shiff Selected
Faces of the Future
Merck Research Laboratories Honored
Living with Breast Cancer
Health Literacy
A Point of View by Julie Gerberding, M.D., M.P.H.
Meet Paige Cramer
Merck Releases 2015/2016 Corporate Responsibility Report
How Merck Animal Health Helped to Curb a New Strain of CIV
Women in Science
2016 Merck Fellowship for Global Health
Meet Daria Hazuda
A Point of View by Dr. Jonathan Cheng
Understanding Head and Neck Cancer
HPV Awareness
Meet Arnaub Chatterjee
Fasting and Diabetes
Understanding Diabetes
Living with Type 2 Diabetes
It's Personal Series
Collaborating to Cure
Meet Mike Thien
Roy Vagelos Honored by American Heart Association
Changing the Statistics
Charting a New Course in Cancer Care
New Approaches to Fighting Cancer
Melanoma... 'Never Walk Alone'
Be Safe In The Sun
America's Diabetes Challenge
World Immunization Week
Merck for Mothers at the Women in the World Summit
Vaccines: Our History, Our Legacy
The Impact of Cancer
Merck’s Commitment to Hepatitis C
Hepatitis C: A Silent Disease and Growing Concern
Using Water Wisely
Meet George W. Merck
Heart Disease
Guided by Research, Inspired by Hope
Why Animal Health Matters
Merck Turns 125
Cervical Health Awareness Month
Rallying to Meet the Need
William Campbell Wins Nobel Prize
Meet Christopher Kistler
Diversity and Inclusion: Good for Business
Understanding Alzheimer’s Disease
Living with HIV
Meet Jason Cheung
Hepatitis C: A Medical — and Social — Diagnosis
The Fight Against Hepatitis C
Saluting Those Who Serve
Lung Cancer: Challenges and Reasons for Hope
Real Innovation
World Diabetes Day
Lung Cancer
Refugee and Migrant Relief Efforts
What is C. difficile
Beyond Tired? So Are They...
Meet Alexander Buitrago Santanilla
Ken Frazier Receives Lifetime Achievement Award
Merck Employees Walk to End Alzheimer’s
Ken Frazier at the Clinton Global Initiative
Helping to Advance a New Set of UN Global Goals
Merck Fellowship for Global Health
2014 Corporate Responsibility Report
New Therapies to Attack Infections
The Race Against Resistance
Identifying the Next Generation of Antibacterial Therapies
The Fight Against Antimicrobial Resistance
Mectizan Donation Program
Meet Paul Reichert
Merck for Mothers at TEDWomen
Meet Spencer Dreher
Merck and HIV/AIDS
Fasting and Diabetes 
Merck's Rule the Real Talk Campaign
Meet Daisy Richardson
Art for All
MSD in Japan: Bringing Back the Beach 
A Commitment to Diabetes Research
A Silent Disease and Growing Concern
Meet Tim Cernak
Melanoma ... Never Walk Alone
Be Safe in the Sun
May is for Mothers
Bone Health Awareness
America's Diabetes Challenge
Pushing to Outpace Superbugs
The Evolution of Cancer Research
Parasites and Your Pets
Meet Ayesha Sitlani
Every Woman Every Child Event
Everyday Heroes
New Approaches to Fighting Cancer
Insomnia
Advancing Oncology Research Through Clinical Trials
Bridging the Gap  in Diabetes Care
Closing the Circle on Rabies
Desafiando la Diabetes
Understanding Diabetes
Helping Empower Women Living with HIV
Diabetes and Travel
Vaccines: Our History, Our Legacy
The Impact of Cancer
A Point of View by Eric Rubin, M.D.
Making a Difference






Inventing For Life


×
Inventing For Life

Inventing For Life






Products


×
Products

Products
Product List A-Z
Vaccines & Prescribing Information 
Prescription Products & Prescribing Information


Oncology Products & Prescribing Information

Animal Health


Product Patents
Authorized Distributors
Vaccine Contracted Distributors




Research


×
Research

Research
Our People, Our Culture

– The MRL Postdoctoral Research Fellow Program




Our R&D Process
What We're Working On
Pipeline


Clinical Trials
Invent with Us
Discover Where Our Research Happens




Licensing


×
Licensing

Business Development & Licensing


Incyte
Moderna
NGM Biopharmaceuticals



BD&L Contacts


News & Events






Newsroom


×
Newsroom

Newsroom
News Releases

– Prescription Medicine News
– Consumer Care News
– Vaccine News
– Research & Development News
– Corporate News
– Financial News
– Corporate Responsibility News
– Animal Health News





Information Centers


– Diabetes
– Ebola
– Hepatitis C
– Oncology


Company Statements

Media Center


Company Snapshot
Social Media






Careers


×
Careers

Careers
Apply Now
What’s Possible?

My Career Journey @Merck Anna Dickstein
My Career Journey @Merck Fran Murphy
My Career Journey @Merck Paige Cramer




Why Merck?


– Diversity At Merck
– From Service to Science
– Prepared for Launch
– Compensation and Benefits


How Will You Invent the Future?

My Career Journey @Merck Frank Clyburn







Canada
MSD Worldwide




Investors


×
Investors

Investors
Product Pipeline
News
Events & Presentations


Stock Info

– Stock Quote & Chart
– Historical Price Look-up
– Investment Calculator
– Dividend History
– Stock Splits
– Analyst Coverage


Financials

– Quarterly Reports
– Annual Reports & Proxy
– SEC Filings




Governance
Investor Resources

– FAQs
– Stockholder Services
– Corporate Responsibility
– Information Request
– Sign up for Email Alerts
– Other
– Contact Us
















Menu


MENU


















ANIMAL HEALTH










Merck Animal Health is a global leader in the research, development, manufacturing and sale of veterinary medicines.

We offer a broad choice of vaccines, anti-infective and antiparasitic drugs, a complete range of fertility management products, pharmaceutical specialty products, innovative delivery solutions, performance technologies and value-added programs, such as pet recovery services and livestock data management tools.
To learn more about our Animal Health business, please visit Merck Animal Health.

                            In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for more information.
                        








Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 



Forward-Looking Statement
Privacy
Terms of Use
Site Map







×Close
Forward-Looking Statement


Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA 
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
                
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. 
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). 
No Duty to Update  
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. 








































x
Worldwide


Merck





Canada
United States





MSD
Merck is known as MSD outside the United States and Canada. Clicking on any of the links below will take you to a website intended for those living outside the United States and Canada.






Algeria – French
Argentina – Spanish
Australia – English
Austria – German 
Belgium – Dutch, French, English
Brazil – Portuguese
Bulgaria – Bulgarian
Caribbean – English
Central America – Spanish
Chile – Spanish
China – Simplified Chinese
Colombia – Spanish
Costa Rica – Spanish
Croatia – Croatian
Czech Republic – Czech
Denmark – Danish
Dominican Republic – Dominican
Ecuador – Spanish
Egypt – English
Estonia – Estonian




Finland – Finnish
France – French
Fulford India – English
Germany – German
Greece – Greek
Hong Kong – Chinese, English
Hungary – Hungarian
India – English
Indonesia – English
Ireland – English
Italy – Italian
Japan – Japanese
Latvia – Latvian
Lithuania – Lithuanian
Malaysia – English
Mexico – Spanish
Montenegro – Serbian
Netherlands – Dutch
New Zealand – English
Norway – Norwegian




Peru – Spanish
Philippines – English
Poland – Polish
Portugal – Portuguese
Puerto Rico – Spanish, English
Romania – Romanian, English
Russia – Russian
Saudi Arabia – English
Serbia – Serbian
Singapore – English
Slovakia – Slovak
Slovenia – Slovene
South Africa  – English
South Korea – Korean
Spain – Spanish
Sweden – Swedish
Switzerland – English, French, German
Taiwan – Traditional Chinese
Thailand – Thai, English
Turkey – Turkish
Ukraine – Ukrainian
United Kingdom – English
Venezuela – Spanish
Vietnam – Vietnamese 








Close




















































Mark C.  Griege: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 8:56 PM ET
Banks

Company Overview of Veritex Holdings, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Mark C.  Griege  Independent Director, Veritex Holdings, Inc.AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.See Board Relationships58$49,397
Background

		Mr. Mark C. Griege co-founded Robertson, Griege & Thoele in 1985 and serves as its Managing Partner. Mr. Griege has been an Independent Director of Veritex Holdings, Inc. since 2009. He has been a Director of Veritex Community Bank since March 7, 2016. He holds a Bachelor of Business Administration from Southern Methodist University in 1981 and a Juris Doctor from University Of Texas School Of Law in 1985.	
	



Corporate Headquarters
8214 Westchester DriveDallas, Texas 75225United StatesPhone: 972-349-6200Fax: --
Board Members Memberships
2009-PresentIndependent DirectorVeritex Holdings, Inc.2016-PresentDirectorVeritex Community Bank
Education
BBA 1981Southern Methodist UniversityJD 1985University of Texas Law School
Other Affiliations
Southern Methodist UniversityUniversity of Texas Law SchoolVeritex Community Bank


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
Total Annual Cash Compensation$28,000Total Calculated Compensation$49,397




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationBrian T. Moynihan Chairman, Chief Executive Officer & PresidentBank of America Corporation$1.5MTimothy J. Sloan Chief Executive Officer, President and DirectorWells Fargo & Company$2.3MDavid R. Brooks Chairman of the Independent Board, Chief Executive Officer and PresidentIndependent Bank Group, Inc.$1.3MCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Veritex Holdings, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



































Mark C. Griege - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Mark C. Griege
Board Member at Veritex Holdings, Inc.


View Full Profile
Are you Mark C. Griege? Claim your profile


 


Sign up for Equilar Atlas and view Mark C. Griege's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Mark C. Griege's  network and community.
												FOLLOW changes in Mark C. Griege's employment and money-in-motion.
												CONNECT with Mark C. Griege through your network of contacts.
												








Mark C. Griege's Executive Work History


Current


Board Member, 
Veritex Holdings, Inc.


Past
To view Mark C. Griege's complete executive work history, sign up now
Age
58

 
 


Mark C. Griege's Biography




			Mark C. Griege has served on our board since 2009. Mr. Griege is a Managing Partner of Robertson, Griege & Thoele, a large independent wealth management firm based in Dallas, which he co-founded in 1985. Mr. Griege received a Bachelor of Business Administration from Southern Methodist University in 1981, and a Juris Doctor from the University of Texas School of Law in 1985. His significant experience and leadership of Robertson, Griege & Thoele bring perspective and knowledge to our board regarding a variety of investments, businesses and leadership, and qualify him to serve on our board.
		
Source: Veritex Holdings, Inc. on 04/10/2017
		
	

 






Sign up for Equilar Atlas and view Mark C. Griege's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Mark C. Griege. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Mark C. Griege's  network and community.
												FOLLOW changes in Mark C. Griege's employment and money-in-motion.
												CONNECT with Mark C. Griege through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Mark C. Griege


















Mark C. Griege's Connections (14)





Sign up now to view Mark C. Griege's 14 connections »









Blake Bozman
Board Member, Veritex Holdings, Inc.









Michael A. Kowalski
Board Member, Veritex Holdings, Inc.









Ray W. Washburne
Board Member, Veritex Holdings, Inc.









Pat S. Bolin
Board Member, Veritex Holdings, Inc.









Noreen E. Skelly
Executive Vice President and Chief Financial Officer, Veritex Holdings, Inc.









Jeff Kesler
Executive Vice President and Chief Lending Executive, Veritex Community Bank, Veritex Holdings, Inc.









William C. Murphy
Vice Chairman, Veritex Holdings, Inc.









Malcolm Holland
Chairman of the Board and Chief Executive Officer; President, Veritex Community Bank, Veritex Holdings, Inc.









John Sughrue
Board Member, Veritex Holdings, Inc.









Michael D. Ilagan
Board Member, Veritex Holdings, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993













 














Merck.com | Products | Prescription-Products | Prescription Products & Prescribing Information


























































WORLDWIDE 
            




Contact Us

Contact Us
FAQ
















Navigation
About Us


×
About Us

About Us
Corporate Responsibility
Reimbursement Support and Patient Assistance Programs

Leadership

– Board of Directors
– Executive Committee


Our Work

Our Work in Antimicrobial Resistance
Our Work in Hepatitis C
Our Work in Diabetes
Our Work in Oncology
Our Work in HIV
Our Work in Vaccines




How We Operate

– Code of Conduct

Our Values and Standards
Our Values and Standards For External Business Partners


– Compliance
– Privacy

– Transparency and Privacy
– Internet Privacy Policy
– Cookie Privacy Commitment
– Cross Border Policy
– Employment Privacy & Data Protection


– Diversity

– Employee Diversity
– Supplier Diversity
Programs and Partnerships
What We Buy
Definitions
Register Potential Supplier
Supplier Diversity






Views and Positions

– Access and Affordability
– Access to Investigational Medicines
– Innovation
– Quality and Safety
– Sales and Marketing
– Responsible Public Policy and Advocacy
Public Policy Position Statements
Trade Association Memberships


Our History

Company Fact Sheet


Our People
Featured Stories

Our Legacy - And Future - in American Manufacturing
Merck's IT Organization Expands into Austin, Texas
MECTIZAN Donation Is One for the Record Books
Journey for Control
A Point of View by Dr. Bao Lam
Fighting Some of the World's Toughest Bacterial Infections
Meet Dan Cua
It Takes a Village
Type 2 Diabetes: A Focus on A1C
May is for Mothers
Pushing to Outpace Superbugs
Merck Announces Enhancements to Family Leave Time
Classical Hodgkin Lymphoma: Facing Cancer in Young Adulthood
World Sleep Day
BeKindAlways4Noah
The Merck-Regenstrief Collaboration
Why Drug Discovery is the Foundation of Merck’s Future
How Chronic Hepatitis C is Impacting Our Veterans
Meet Gokul Swaminathan
Merck Honors Research Microbiologist H. Boyd Woodruff, Ph.D.
Merck Uses Amazon Web Services to Develop Voice-Enabled Solutions
Cancer Needs Cures. Still.
Merck Be Well Challenge 2016 — Bringing the Outside In
A Point of View by Adam Schechter, president of Global Human Health at Merck
Your Cancer Game Plan
Merck Foundation Grant Helps Expand Project ECHO
Merck’s Commitment to Prevention and Care for NCDs
Meet Jay Schiller
Merck Research Laboratories Expands into South San Francisco
Test. Talk. Take. Action.
Bridging the Gap in Diabetes Care
World Diabetes Day 2016
Meet Harriet Johnson
Merck Employees Surpass Goal of 125,000 Volunteer Hours
Merck for Mothers  Pep Talk
Meet Commander Adam Scott
Meet Noreen Rizvi
Ebola Outbreak
A Point of View by Dr. Roger Dansey
A Point of View by Dr. Gregory Lubiniecki
Merck’s Susan Shiff Selected
Faces of the Future
Merck Research Laboratories Honored
Living with Breast Cancer
Health Literacy
A Point of View by Julie Gerberding, M.D., M.P.H.
Meet Paige Cramer
Merck Releases 2015/2016 Corporate Responsibility Report
How Merck Animal Health Helped to Curb a New Strain of CIV
Women in Science
2016 Merck Fellowship for Global Health
Meet Daria Hazuda
A Point of View by Dr. Jonathan Cheng
Understanding Head and Neck Cancer
HPV Awareness
Meet Arnaub Chatterjee
Fasting and Diabetes
Understanding Diabetes
Living with Type 2 Diabetes
It's Personal Series
Collaborating to Cure
Meet Mike Thien
Roy Vagelos Honored by American Heart Association
Changing the Statistics
Charting a New Course in Cancer Care
New Approaches to Fighting Cancer
Melanoma... 'Never Walk Alone'
Be Safe In The Sun
America's Diabetes Challenge
World Immunization Week
Merck for Mothers at the Women in the World Summit
Vaccines: Our History, Our Legacy
The Impact of Cancer
Merck’s Commitment to Hepatitis C
Hepatitis C: A Silent Disease and Growing Concern
Using Water Wisely
Meet George W. Merck
Heart Disease
Guided by Research, Inspired by Hope
Why Animal Health Matters
Merck Turns 125
Cervical Health Awareness Month
Rallying to Meet the Need
William Campbell Wins Nobel Prize
Meet Christopher Kistler
Diversity and Inclusion: Good for Business
Understanding Alzheimer’s Disease
Living with HIV
Meet Jason Cheung
Hepatitis C: A Medical — and Social — Diagnosis
The Fight Against Hepatitis C
Saluting Those Who Serve
Lung Cancer: Challenges and Reasons for Hope
Real Innovation
World Diabetes Day
Lung Cancer
Refugee and Migrant Relief Efforts
What is C. difficile
Beyond Tired? So Are They...
Meet Alexander Buitrago Santanilla
Ken Frazier Receives Lifetime Achievement Award
Merck Employees Walk to End Alzheimer’s
Ken Frazier at the Clinton Global Initiative
Helping to Advance a New Set of UN Global Goals
Merck Fellowship for Global Health
2014 Corporate Responsibility Report
New Therapies to Attack Infections
The Race Against Resistance
Identifying the Next Generation of Antibacterial Therapies
The Fight Against Antimicrobial Resistance
Mectizan Donation Program
Meet Paul Reichert
Merck for Mothers at TEDWomen
Meet Spencer Dreher
Merck and HIV/AIDS
Fasting and Diabetes 
Merck's Rule the Real Talk Campaign
Meet Daisy Richardson
Art for All
MSD in Japan: Bringing Back the Beach 
A Commitment to Diabetes Research
A Silent Disease and Growing Concern
Meet Tim Cernak
Melanoma ... Never Walk Alone
Be Safe in the Sun
May is for Mothers
Bone Health Awareness
America's Diabetes Challenge
Pushing to Outpace Superbugs
The Evolution of Cancer Research
Parasites and Your Pets
Meet Ayesha Sitlani
Every Woman Every Child Event
Everyday Heroes
New Approaches to Fighting Cancer
Insomnia
Advancing Oncology Research Through Clinical Trials
Bridging the Gap  in Diabetes Care
Closing the Circle on Rabies
Desafiando la Diabetes
Understanding Diabetes
Helping Empower Women Living with HIV
Diabetes and Travel
Vaccines: Our History, Our Legacy
The Impact of Cancer
A Point of View by Eric Rubin, M.D.
Making a Difference






Inventing For Life


×
Inventing For Life

Inventing For Life






Products


×
Products

Products
Product List A-Z
Vaccines & Prescribing Information 
Prescription Products & Prescribing Information


Oncology Products & Prescribing Information

Animal Health


Product Patents
Authorized Distributors
Vaccine Contracted Distributors




Research


×
Research

Research
Our People, Our Culture

– The MRL Postdoctoral Research Fellow Program




Our R&D Process
What We're Working On
Pipeline


Clinical Trials
Invent with Us
Discover Where Our Research Happens




Licensing


×
Licensing

Business Development & Licensing


Incyte
Moderna
NGM Biopharmaceuticals



BD&L Contacts


News & Events






Newsroom


×
Newsroom

Newsroom
News Releases

– Prescription Medicine News
– Consumer Care News
– Vaccine News
– Research & Development News
– Corporate News
– Financial News
– Corporate Responsibility News
– Animal Health News





Information Centers


– Diabetes
– Ebola
– Hepatitis C
– Oncology


Company Statements

Media Center


Company Snapshot
Social Media






Careers


×
Careers

Careers
Apply Now
What’s Possible?

My Career Journey @Merck Anna Dickstein
My Career Journey @Merck Fran Murphy
My Career Journey @Merck Paige Cramer




Why Merck?


– Diversity At Merck
– From Service to Science
– Prepared for Launch
– Compensation and Benefits


How Will You Invent the Future?

My Career Journey @Merck Frank Clyburn







Canada
MSD Worldwide




Investors


×
Investors

Investors
Product Pipeline
News
Events & Presentations


Stock Info

– Stock Quote & Chart
– Historical Price Look-up
– Investment Calculator
– Dividend History
– Stock Splits
– Analyst Coverage


Financials

– Quarterly Reports
– Annual Reports & Proxy
– SEC Filings




Governance
Investor Resources

– FAQs
– Stockholder Services
– Corporate Responsibility
– Information Request
– Sign up for Email Alerts
– Other
– Contact Us
















Menu


MENU


















PRESCRIPTION PRODUCTS &PRESCRIBING INFORMATION










Our core business is the discovery and development of prescription medicines for diseases and conditions that impact millions of people. 
We invest billions of research dollars to find medicines that can help improve lives. Today, Merck has more than 50 prescription products in key therapeutic areas, such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, immunology and women's health.

All Products A-Z
By Therapeutic Area






A – G    
											H – O    
											P – Z




A – G





ANTIVENIN™
											(LATRODECTUS MACTANS)
											(Black Widow Spider Antivenin)
Prescribing Information


ASMANEX® HFA
											(mometasone furoate) inhalation aerosol, for oral inhalation use
Prescribing Information
Patient Product Information




ASMANEX® TWISTHALER®
											(mometasone furoate inhalation powder)
Prescribing Information
Patient Product Information

Product website


AVELOX®
											(moxifloxacin hydrochloride) Tablet, film-coated
Prescribing Information
Medication Guide





AVELOX® I.V.
											(moxifloxacin hydrochloride) Injection, solution for IV use
Prescribing Information
Medication Guide


BCG Vaccine (For Percutaneous Use)
Prescribing Information
Instructions for Use




BELSOMRA®
											(suvorexant) tablets, for oral use, C-IV
Prescribing Information
Medication Guide
Product website


BRIDION®
											(sugammadex) Injection, for intravenous use
Prescribing Information




CANCIDAS®
											(caspofungin acetate) for Injection, for intravenous use
Prescribing Information



CELESTONE®SOLUSPAN®
											(betamethasone sodium phosphate and betamethasone acetate)
                                            Injectable Suspension, USP 30 mg/5 mL (6 mg/mL)
Prescribing Information




CLARINEX®
											(desloratadine) Tablets and Oral Solution for oral use 
Prescribing Information
Patient Product Information



CLARINEX-D®12 HOUR
											Extended Release Tablets
											(desloratadine/pseudoephedrine sulfate) for oral use
Prescribing Information
Patient Product Information








COZAAR® 
											(LOSARTAN POTASSIUM TABLETS)
Prescribing Information
Patient Product Information


CRIXIVAN®
											(INDINAVIR SULFATE) CAPSULES
Prescribing Information
Patient Product Information




CUBICIN®
											(daptomycin for injection) for Intravenous Use
Prescribing Information


CUBICIN®RF
											(daptomycin for injection), for intravenous use
Prescribing Information




Cyclessa®Tablets
											(desogestrel and ethinyl estradiol USP) 
Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary


Desogen® Tablets
											(desogestrel and ethinyl estradiol tablets USP)
Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary




DIFICID®
											(fidaxomicin) tablets, for oral use
Prescribing Information


DIPROLENE® AF
											(augmented betamethasone dipropionate) Cream, 0.05% for topical use
Prescribing Information 




DIPROLENE®
											(augmented betamethasone dipropionate) Lotion, 0.05% for topical use
Prescribing Information 


DIPROLENE®
											(augmented betamethasone dipropionate) Ointment, 0.05% for topical use
Prescribing Information 




DULERA®
											(mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use
Prescribing Information
Medication Guide
Product website


ELOCON®
											(mometasone furoate) Cream, 0.1% for topical use
Prescribing Information




ELOCON®
											(mometasone furoate) Lotion, 0.1% for topical use
Prescribing Information


ELOCON®
											(mometasone furoate) Ointment, 0.1% for topical use
Prescribing Information





EMEND®
											(aprepitant) capsules (aprepitant) for oral suspension
Prescribing Information
Patient Product Information
Instructions for Use
Product website


EMEND®
											(fosaprepitant dimeglumine) for injection, for intravenous use
Prescribing Information (5.4 mg EDTA formulation)
Prescribing Information (18.8 mg EDTA formulation)
Patient Product Information





ENTEREG® 
											(alvimopan) capsules, for oral use
Prescribing Information 


Follistim® AQ Cartridge
											(follitropin beta injection) for subcutaneous use
Prescribing Information 
Patient Product Information and Instructions for Use




Follistim® AQ
											(follitropin beta injection) for subcutaneous or intramuscular use
Prescribing Information
Patient Product Information and Instructions for Use


FORADIL® AEROLIZER®
											(formoterol fumarate inhalation powder)
Prescribing Information
Medication Guide




FOSAMAX®
											(alendronate sodium) tablets and 
											oral solution
Prescribing Information
Medication Guide


FOSAMAX® PLUS D
											(alendronate sodium/cholecalciferol) tablets
Prescribing Information
Medication Guide




Ganirelix Acetate InjectionFOR SUBCUTANEOUS USE ONLY
Prescribing Information


GARDASIL®
											[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
Prescribing Information
Patient Product Information
Product website




GARDASIL®9
											(Human Papillomavirus 9-valent Vaccine, Recombinant)
											Suspension for intramuscular injection
Prescribing Information
Patient Product Information


GRASTEK®
											(Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use
Prescribing Information
Medication Guide
Product website




GUANIDINE HYDROCHLORIDE Tablets
Prescribing Information







Top






H to O




HYZAAR®
											(LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS3)
Prescribing Information
Patient Product Information


IMPLANON®
											(etonogestrel implant), for subdermal use
Prescribing Information
Patient Product Information
Patient Consent Form 
Product website





INTEGRILIN®
											(eptifibatide) InjectionFor Intravenous Administration
Prescribing Information


INTRON®A
											(Interferon alfa-2b, recombinant For Injection)

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use – Powder for Solution (5 mL diluent)
Instructions for Use – Solution for Injection
Product website




INVANZ®
											(ertapenem for injection) for intravenous (IV) or intramuscular (IM) use
Prescribing Information
Product website


ISENTRESS® (raltegravir) film-coated tablets, for oral use
ISENTRESS® HD (raltegravir) film-coated tablets, for oral use
ISENTRESS® (raltegravir) chewable tablets, for oral use
ISENTRESS® (raltegravir) for oral suspension
Prescribing Information
Patient Product Information
Instructions for Use
Product website




JANUMET®
											(sitagliptin and metformin HCl) tablets
Prescribing Information
Medication Guide
Product website


JANUMET®XR
											(sitagliptin and metformin HCl extended-release) tablets
Prescribing Information
Medication Guide
Product website




JANUVIA®
											(sitagliptin) Tablets
Prescribing Information
Medication Guide
Product website



KEYTRUDA® (pembrolizumab) for injection, for intravenous use
KEYTRUDA® (pembrolizumab) injection, for intravenous use
Prescribing Information
Medication Guide
Product website





LOTRISONE® Cream
											(clotrimazole and betamethasone dipropionate)
Prescribing Information
Patient Product Information


MAXALT®
											(rizatriptan benzoate) tablets, for oral use
Prescribing Information
Patient Product Information




MAXALT-MLT®
(rizatriptan benzoate) orally disintegrating tablets
Prescribing Information
Patient Product Information



M-M-R® II
											(MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE)
Prescribing Information
Patient Product Information




NASONEX®
											(mometasone furoate monohydrate) Nasal Spray, 50 mcg†
											†calculated on the anhydrous basis
Prescribing Information
Patient Product Information
Product website


NEXPLANON®
											(etonogestrel implant) Radiopaque 
											Subdermal Use Only
Prescribing Information
Patient Product Information 
Patient Consent Form




NITRO-DUR®
											(nitroglycerin) Transdermal Infusion System
Prescribing Information
Patient Product Information


NOXAFIL®
											(posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension 
Prescribing Information
Patient Product Information




NuvaRing®
											(etonogestrel/ethinyl estradiol vaginal ring)
Prescribing Information
Patient Product Information
Instructions for Use
Product website







Top







P to Z




Liquid Pedvax HIB®
											[Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)]
Prescribing Information


PEGINTRON®
											(peginterferon alfa-2b) injection, for Subcutaneous Use
Prescribing Information (1.25 mL diluent)
Prescribing Information (5 mL diluent)
Medication Guide
Instructions for Use – Powder for Injection (traditional vial and syringe - 1.25 mL diluent)
Instructions for Use – Powder for Injection (traditional vial and syringe - 5 mL diluent)
Instructions for Use – PegIntron REDIPEN®
Product website





PNEUMOVAX® 23 
											(pneumococcal vaccine polyvalent) Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injection
Prescribing Information
Patient Product Information
Product website 


Pregnyl®
											(chorionic gonadotropin for injection USP)
Prescribing Information





PRIMAXIN® I.V.
											(IMIPENEM AND CILASTATIN FOR INJECTION) 
Prescribing Information
Instructions for Use


PRINIVIL®
											(LISINOPRIL) TABLETS
Prescribing Information





PROPECIA®
											(finasteride) tablets for oral use
Prescribing Information
Patient Product Information


ProQuad®
											Measles, Mumps, Rubella and Varicella Virus Vaccine Live
											Lyophilized preparation for subcutaneous injection
Prescribing Information (NDC 0006-4999-00)
Prescribing Information (NDC 0006-4171-00)




PROSCAR®
											(finasteride) Tablets
Prescribing Information
Patient Product Information


PROVENTIL®HFA
											(albuterol sulfate) Inhalation Aerosol
Prescribing Information
Patient Product Information
Product website




RAGWITEK®
											(Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use
Prescribing Information
Medication Guide
Product website


REBETOL®
											(ribavirin USP) Capsules, Oral Solution
Prescribing Information
Medication Guide




RECOMBIVAX HB®
											HEPATITIS B VACCINE (RECOMBINANT)
Prescribing Information


REMERON®
											(mirtazapine) Tablets
Prescribing Information
Medication Guide




REMERONSolTab®
											(mirtazapine) Orally Disintegrating Tablets
Prescribing Information
Medication Guide


RENFLEXIS™
											(infliximab-abda) for injection, for intravenous use
Prescribing Information
Medication Guide





RotaTeq®
											(Rotavirus Vaccine, Live, Oral, Pentavalent) Oral Solution
Prescribing Information
Patient Product Information





SINEMET®
											(carbidopa-levodopa) Tablets
Prescribing Information


SINEMET® CR
											(carbidopa-levodopa) Sustained-Release Tablets
Prescribing Information




SINGULAIR®
											(montelukast sodium) Tablets, Chewable Tablets, and Oral Granules
Prescribing Information
Patient Product Information


SIVEXTRO®
											(tedizolid phosphate) for injection, for intravenous use
											(tedizolid phosphate) tablet, for oral use
Prescribing Information




STROMECTOL®
											(IVERMECTIN) TABLETS
Prescribing Information


SYLATRON™
											(peginterferon alfa-2b) for injection, for subcutaneous use

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use (5 mL diluent)





TEMODAR®
											(temozolomide) Capsules
Prescribing Information
Patient Product Information
Pharmacist Information


TEMODAR®
											(temozolomide) for Injection
Prescribing Information
Patient Product Information
Pharmacist Information




TICE® BCG
											BCG LIVE (FOR INTRAVESICAL USE)
Prescribing Information



TRUSOPT®
											(dorzolamide hydrochloride ophthalmic solution) Sterile Ophthalmic Solution 2%
Prescribing Information
Instructions for Use




VAQTA®
											(Hepatitis A Vaccine, Inactivated)Suspension for Intramuscular Injection
Prescribing Information


VARIVAX®
											Varicella Virus Vaccine Live
Prescribing Information
Patient Product Information




VICTRELIS®
											(boceprevir) Capsules for oral use
Prescribing Information
Medication Guide 


VYTORIN®
											(ezetimibe and simvastatin) Tablets
Prescribing Information
Patient Product Information
Product website




ZEMURON®
											(rocuronium bromide) injection solution for intravenous use
Prescribing Information


ZEPATIER®
											(elbasvir and grazoprevir) tablets, for oral use
Prescribing Information
Patient Product Information




ZERBAXA™
											(ceftolozane and tazobactam) for injection, for intravenous use 
Prescribing Information


ZETIA®
											(ezetimibe) Tablets
Prescribing Information
Patient Product Information
Product website




ZINPLAVA™
											(bezlotoxumab) injection, for intravenous use
Prescribing Information
Patient Product Information


ZOCOR®
											(simvastatin) Tablets
Prescribing Information




ZOLINZA®
											(vorinostat) Capsules
Prescribing Information
Patient Product Information


ZONTIVITY®
											(vorapaxar) Tablets 2.08 mg*, for oral use *Equivalent to 2.5 mg vorapaxar sulfate
Prescribing Information
Medication Guide




ZOSTAVAX®
											(Zoster Vaccine Live) Suspension for subcutaneous injection
Prescribing Information
Patient Product Information
Product website








Top




Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck, its subsidiaries or affiliates, except as noted.

 





													Cardiovascular
												




COZAAR® 
												(
												)
Prescribing Information
Patient Product Information


HYZAAR®
												(LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS3)
Prescribing Information
Patient Product Information



INTEGRILIN®
												(eptifibatide) Injection For Intravenous Administration
Prescribing Information



NITRO-DUR®
												(nitroglycerin)Transdermal Infusion System
Prescribing Information 
Patient Product Information

PRINIVIL®
												(LISINOPRIL) TABLETS
Prescribing Information
VYTORIN®
												(ezetimibe and simvastatin) Tablets
Prescribing Information
Patient Product Information
Product website
ZETIA®
												(ezetimibe) Tablets
Prescribing Information
Patient Product Information
Product website 
ZOCOR®
												(simvastatin) Tablets
Prescribing Information 

ZONTIVITY®
												(vorapaxar) Tablets 2.08 mg*, for oral use *Equivalent to 2.5 mg vorapaxar sulfate
Prescribing Information
Medication Guide







													Endocrinology
												




FOSAMAX®
(alendronate sodium) tablets and oral solution
Prescribing Information
Medication Guide


FOSAMAX® PLUS D
(alendronate sodium/cholecalciferol) tablets
Prescribing Information
Medication Guide


JANUMET®
(sitagliptin and metformin HCl) tablets
Prescribing Information

Medication Guide
Product website

JANUMET®XR
(sitagliptin and metformin HCl extended-release) tablets
Prescribing Information
Medication Guide
Product website 

JANUVIA®
(sitagliptin) Tablets
Prescribing Information

Medication Guide
Product website 


Pregnyl™
(chorionic gonadotropin for injection USP)
Prescribing Information








													Immunology
												




CELESTONE®SOLUSPAN®
(betamethasone sodium phosphate and betamethasone acetate)
                                                Injectable Suspension, USP 30 mg/5 mL (6 mg/mL)
Prescribing Information
RENFLEXIS™
(infliximab-abda) for injection, for intravenous use
Prescribing Information
Medication Guide








													Infectious Disease
												




AVELOX®
(moxifloxacin hydrochloride) Tablet, film-coated
Prescribing Information
Medication Guide
AVELOX® I.V.
(moxifloxacin hydrochloride) Injection, solution for IV use
Prescribing Information
Medication Guide
CANCIDAS®
(caspofungin acetate) for Injection, for intravenous use
Prescribing Information
CRIXIVAN®
(INDINAVIR SULFATE) CAPSULES
Prescribing Information
Patient Product Information
CUBICIN®
(daptomycin for injection) for Intravenous Use
Prescribing Information
CUBICIN®RF
(daptomycin for injection), for intravenous use
Prescribing Information
DIFICID®
(fidaxomicin) tablets, for oral use
Prescribing Information
INVANZ®
(ertapenem for Injection) for intravenous (IV) or intramuscular (IM) use
Prescribing Information
Product website
ISENTRESS® (raltegravir) film-coated tablets, for oral use
ISENTRESS® HD (raltegravir) film-coated tablets, for oral use
ISENTRESS® (raltegravir) chewable tablets, for oral use
ISENTRESS® (raltegravir) for oral suspension
Prescribing Information
Patient Product Information
Instructions for Use
Product website

Noxafil®
(posaconazole) injection 18mg/mL, delayed-release tablets 100 mg, and oral suspension 40 mg/mL
Prescribing Information
Patient Product Information


PEGINTRON®
(peginterferon alfa-2b) injection, for Subcutaneous Use
Prescribing Information (1.25 mL diluent)
Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use – Powder for Injection (traditional vial and syringe - 1.25 mL diluent)
Instructions for Use – Powder for Injection (traditional vial and syringe - 5 mL diluent)
Instructions for Use – PegIntron REDIPEN®
Product website
PRIMAXIN® I.V.
(IMIPENEM AND CILASTATIN FOR INJECTION)
Prescribing Information
Instructions for Use
REBETOL®
(ribavirin USP) Capsules, and Oral Solution
Prescribing Information
Medication Guide
SIVEXTRO®
(tedizolid phosphate) for injection, for intravenous use
SIVEXTRO®
(tedizolid phosphate) tablet, for oral use
Prescribing Information
STROMECTOL®
(IVERMECTIN) TABLETS
Prescribing Information
VICTRELIS®
(boceprevir) Capsules for oral use
Prescribing Information
Medication Guide 
ZEPATIER®
(elbasvir and grazoprevir) tablets, for oral use
Prescribing Information
Patient Product Information
ZERBAXA™
(ceftolozane and tazobactam) for injection, for intravenous use
Prescribing Information
ZINPLAVA™
(bezlotoxumab) injection, for intravenous use
Prescribing Information
Patient Product Information







													Neuroscience
												




BELSOMRA®
(suvorexant) tablets, for oral use, C-IV
Prescribing Information
Medication Guide
Product website
BRIDION®
(sugammadex) Injection, for intravenous use
Prescribing Information
GUANIDINE HYDROCHLORIDE Tablets
Prescribing Information
MAXALT®
(rizatriptan benzoate) tablets, for oral use
MAXALT-MLT®
(rizatriptan benzoate) orally disintegrating tablets
Prescribing Information
Patient Product Information
REMERON®
(mirtazapine) Tablets
Prescribing Information
Medication Guide
REMERONSolTab®
(mirtazapine) Orally Disintegrating Tablets
Prescribing Information
Medication Guide 
SINEMET®
(carbidopa-levodopa) Tablets
Prescribing Information
SINEMET® CR
(carbidopa-levodopa) Sustained-Release Tablets
Prescribing Information
ZEMURON®
(rocuronium bromide) injection solution for intravenous use
Prescribing Information







													Oncology
												




EMEND®
(aprepitant) capsules  (aprepitant) for oral suspension
Prescribing Information
Patient Product Information
Instructions for Use
Product website
EMEND®
(fosaprepitant dimeglumine) for injection, for intravenous use
Prescribing Information (5.4 mg EDTA formulation)
Prescribing Information (18.8 mg EDTA formulation)
Patient Product Information

INTRON® A 
Interferon alfa-2b, recombinant For Injection

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use – Powder for Solution (5 mL diluent)
Instructions for Use – Solution for Injection
Product website
KEYTRUDA® (pembrolizumab) for injection, for intravenous use
KEYTRUDA® (pembrolizumab) injection, for intravenous use
Prescribing Information
Medication Guide
Product website
SYLATRON™
(peginterferon alfa-2b) for Injection, for subcutaneous use

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use (5 mL diluent)

TEMODAR® Capsules
(temozolomide)
Prescribing Information
Patient Product Information
Pharmacist Information
TEMODAR® for Injection
(temozolomide)
Prescribing Information
Patient Product Information
Pharmacist Information
TICE® BCG
BCG LIVE (FOR INTRAVESICAL USE)
Prescribing Information

ZOLINZA®
(vorinostat) Capsules
Prescribing Information
Patient Product Information








													Ophthalmics
												







TRUSOPT®
(dorzolamide hydrochloride ophthalmic solution)Sterile Ophthalmic Solution 2%
Prescribing Information
Instructions for Use







													Respiratory
												





ASMANEX® HFA
(mometasone furoate) inhalation aerosol, for oral inhalation use
Prescribing Information
Patient Product Information
ASMANEX® TWISTHALER®
(mometasone furoate inhalation powder)
Prescribing Information
Patient Product Information
Product website

CLARINEX®
(desloratadine) Tablets and Oral Solution for oral use
Prescribing Information
Patient Product Information

CLARINEX-D®12 HOUR
Extended Release Tablets
												(desloratadine/pseudoephedrine sulfate) for oral use
Prescribing Information
Patient Product Information


DULERA®
(mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use
Prescribing Information
Medication Guide
Product website
FORADIL® AEROLIZER®
(formoterol fumarate inhalation powder)
Prescribing Information
Medication Guide
GRASTEK®
(Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use
Prescribing Information
Medication Guide
Product website
NASONEX®
(mometasone furoate monohydrate) Nasal Spray, 50 mcg†
												†calculated on the anhydrous basis
Prescribing Information
Patient Product Information
Product website
PROVENTIL®HFA
(albuterol sulfate) Inhalation Aerosol
Prescribing Information
Patient Product Information
Product website
RAGWITEK®
(Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use
Prescribing Information
Medication Guide
Product website
SINGULAIR®
(montelukast sodium) Tablets, Chewable Tablets, and Oral Granules
Prescribing Information
Patient Product Information








														Urology
													





PROSCAR®
(finasteride) Tablets
Prescribing Information
Patient Product Information







														Women's Health
													




Cyclessa® Tablets
(desogestrel and ethinyl estradiol USP)
Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary
Desogen® Tablets
(desogestrel and ethinyl estradiol tablets USP)
Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary
Follistim®AQ Cartridge
(follitropin beta injection) for subcutaneous use
Prescribing Information
Patient Product Information and Instructions for Use
Follistim® AQ
(follitropin beta injection) for subcutaneous or intramuscular use
Prescribing Information
Patient Product Information and Instructions for Use

Ganirelix Acetate InjectionFOR SUBCUTANEOUS USE ONLY
Prescribing Information
IMPLANON®
(etonogestrel implant), for subdermal use
Prescribing Information
Patient Product Information
Patient Consent Form 
Product website
NEXPLANON®
(etonogestrel implant) Radiopaque Subdermal Use Only
Prescribing Information
Patient Product Information 
Patient Consent Form 
NuvaRing®
(etonogestrel/ethinyl estradiol vaginal ring)
Prescribing Information
Patient Product Information
Instructions for Use
Product website 







														Other
													




ANTIVENIN™
(LATRODECTUS MACTANS)
													(Black Widow Spider Antivenin)
Prescribing Information
DIPROLENE®AF
(augmented betamethasone dipropionate) Cream, 0.05% for topical use
Prescribing Information
DIPROLENE®
(augmented betamethasone dipropionate) Lotion, 0.05% for topical use
Prescribing Information
DIPROLENE®
(augmented betamethasone dipropionate) Ointment, 0.05% for topical use
Prescribing Information
ELOCON®
(mometasone furoate) Cream, 0.1% for topical use
Prescribing Information
ELOCON®
(mometasone furoate) Lotion, 0.1% for topical use
Prescribing Information
ELOCON®
(mometasone furoate) Ointment, 0.1% for topical use
Prescribing Information
EMEND®
(aprepitant) capsules  (aprepitant) for oral suspension
Prescribing Information
Patient Product Information
Instructions for Use
Product website
ENTEREG®
													(alvimopan) capsules, for oral use
Prescribing Information
LOTRISONE® Cream(clotrimazole and betamethasone dipropionate)
Prescribing Information
Patient Product Information
PROPECIA®
(finasteride) tablets for oral use
Prescribing Information
Patient Product Information



Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck, its subsidiaries or affiliates, except as noted.






Merck Authorized Distributors


Get Merck Medicines & Vaccines for Free
Patient Assistance Program


REPORT ADVERSE EXPERIENCE
To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080











Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 



Forward-Looking Statement
Privacy
Terms of Use
Site Map







×Close
Forward-Looking Statement


Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA 
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
                
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. 
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). 
No Duty to Update  
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. 








































x
Worldwide


Merck





Canada
United States





MSD
Merck is known as MSD outside the United States and Canada. Clicking on any of the links below will take you to a website intended for those living outside the United States and Canada.






Algeria – French
Argentina – Spanish
Australia – English
Austria – German 
Belgium – Dutch, French, English
Brazil – Portuguese
Bulgaria – Bulgarian
Caribbean – English
Central America – Spanish
Chile – Spanish
China – Simplified Chinese
Colombia – Spanish
Costa Rica – Spanish
Croatia – Croatian
Czech Republic – Czech
Denmark – Danish
Dominican Republic – Dominican
Ecuador – Spanish
Egypt – English
Estonia – Estonian




Finland – Finnish
France – French
Fulford India – English
Germany – German
Greece – Greek
Hong Kong – Chinese, English
Hungary – Hungarian
India – English
Indonesia – English
Ireland – English
Italy – Italian
Japan – Japanese
Latvia – Latvian
Lithuania – Lithuanian
Malaysia – English
Mexico – Spanish
Montenegro – Serbian
Netherlands – Dutch
New Zealand – English
Norway – Norwegian




Peru – Spanish
Philippines – English
Poland – Polish
Portugal – Portuguese
Puerto Rico – Spanish, English
Romania – Romanian, English
Russia – Russian
Saudi Arabia – English
Serbia – Serbian
Singapore – English
Slovakia – Slovak
Slovenia – Slovene
South Africa  – English
South Korea – Korean
Spain – Spanish
Sweden – Swedish
Switzerland – English, French, German
Taiwan – Traditional Chinese
Thailand – Thai, English
Turkey – Turkish
Ukraine – Ukrainian
United Kingdom – English
Venezuela – Spanish
Vietnam – Vietnamese 








Close


















































 














Merck.com | Products | Home


























































WORLDWIDE 
            




Contact Us

Contact Us
FAQ
















Navigation
About Us


×
About Us

About Us
Corporate Responsibility
Reimbursement Support and Patient Assistance Programs

Leadership

– Board of Directors
– Executive Committee


Our Work

Our Work in Antimicrobial Resistance
Our Work in Hepatitis C
Our Work in Diabetes
Our Work in Oncology
Our Work in HIV
Our Work in Vaccines




How We Operate

– Code of Conduct

Our Values and Standards
Our Values and Standards For External Business Partners


– Compliance
– Privacy

– Transparency and Privacy
– Internet Privacy Policy
– Cookie Privacy Commitment
– Cross Border Policy
– Employment Privacy & Data Protection


– Diversity

– Employee Diversity
– Supplier Diversity
Programs and Partnerships
What We Buy
Definitions
Register Potential Supplier
Supplier Diversity






Views and Positions

– Access and Affordability
– Access to Investigational Medicines
– Innovation
– Quality and Safety
– Sales and Marketing
– Responsible Public Policy and Advocacy
Public Policy Position Statements
Trade Association Memberships


Our History

Company Fact Sheet


Our People
Featured Stories

Our Legacy - And Future - in American Manufacturing
Merck's IT Organization Expands into Austin, Texas
MECTIZAN Donation Is One for the Record Books
Journey for Control
A Point of View by Dr. Bao Lam
Fighting Some of the World's Toughest Bacterial Infections
Meet Dan Cua
It Takes a Village
Type 2 Diabetes: A Focus on A1C
May is for Mothers
Pushing to Outpace Superbugs
Merck Announces Enhancements to Family Leave Time
Classical Hodgkin Lymphoma: Facing Cancer in Young Adulthood
World Sleep Day
BeKindAlways4Noah
The Merck-Regenstrief Collaboration
Why Drug Discovery is the Foundation of Merck’s Future
How Chronic Hepatitis C is Impacting Our Veterans
Meet Gokul Swaminathan
Merck Honors Research Microbiologist H. Boyd Woodruff, Ph.D.
Merck Uses Amazon Web Services to Develop Voice-Enabled Solutions
Cancer Needs Cures. Still.
Merck Be Well Challenge 2016 — Bringing the Outside In
A Point of View by Adam Schechter, president of Global Human Health at Merck
Your Cancer Game Plan
Merck Foundation Grant Helps Expand Project ECHO
Merck’s Commitment to Prevention and Care for NCDs
Meet Jay Schiller
Merck Research Laboratories Expands into South San Francisco
Test. Talk. Take. Action.
Bridging the Gap in Diabetes Care
World Diabetes Day 2016
Meet Harriet Johnson
Merck Employees Surpass Goal of 125,000 Volunteer Hours
Merck for Mothers  Pep Talk
Meet Commander Adam Scott
Meet Noreen Rizvi
Ebola Outbreak
A Point of View by Dr. Roger Dansey
A Point of View by Dr. Gregory Lubiniecki
Merck’s Susan Shiff Selected
Faces of the Future
Merck Research Laboratories Honored
Living with Breast Cancer
Health Literacy
A Point of View by Julie Gerberding, M.D., M.P.H.
Meet Paige Cramer
Merck Releases 2015/2016 Corporate Responsibility Report
How Merck Animal Health Helped to Curb a New Strain of CIV
Women in Science
2016 Merck Fellowship for Global Health
Meet Daria Hazuda
A Point of View by Dr. Jonathan Cheng
Understanding Head and Neck Cancer
HPV Awareness
Meet Arnaub Chatterjee
Fasting and Diabetes
Understanding Diabetes
Living with Type 2 Diabetes
It's Personal Series
Collaborating to Cure
Meet Mike Thien
Roy Vagelos Honored by American Heart Association
Changing the Statistics
Charting a New Course in Cancer Care
New Approaches to Fighting Cancer
Melanoma... 'Never Walk Alone'
Be Safe In The Sun
America's Diabetes Challenge
World Immunization Week
Merck for Mothers at the Women in the World Summit
Vaccines: Our History, Our Legacy
The Impact of Cancer
Merck’s Commitment to Hepatitis C
Hepatitis C: A Silent Disease and Growing Concern
Using Water Wisely
Meet George W. Merck
Heart Disease
Guided by Research, Inspired by Hope
Why Animal Health Matters
Merck Turns 125
Cervical Health Awareness Month
Rallying to Meet the Need
William Campbell Wins Nobel Prize
Meet Christopher Kistler
Diversity and Inclusion: Good for Business
Understanding Alzheimer’s Disease
Living with HIV
Meet Jason Cheung
Hepatitis C: A Medical — and Social — Diagnosis
The Fight Against Hepatitis C
Saluting Those Who Serve
Lung Cancer: Challenges and Reasons for Hope
Real Innovation
World Diabetes Day
Lung Cancer
Refugee and Migrant Relief Efforts
What is C. difficile
Beyond Tired? So Are They...
Meet Alexander Buitrago Santanilla
Ken Frazier Receives Lifetime Achievement Award
Merck Employees Walk to End Alzheimer’s
Ken Frazier at the Clinton Global Initiative
Helping to Advance a New Set of UN Global Goals
Merck Fellowship for Global Health
2014 Corporate Responsibility Report
New Therapies to Attack Infections
The Race Against Resistance
Identifying the Next Generation of Antibacterial Therapies
The Fight Against Antimicrobial Resistance
Mectizan Donation Program
Meet Paul Reichert
Merck for Mothers at TEDWomen
Meet Spencer Dreher
Merck and HIV/AIDS
Fasting and Diabetes 
Merck's Rule the Real Talk Campaign
Meet Daisy Richardson
Art for All
MSD in Japan: Bringing Back the Beach 
A Commitment to Diabetes Research
A Silent Disease and Growing Concern
Meet Tim Cernak
Melanoma ... Never Walk Alone
Be Safe in the Sun
May is for Mothers
Bone Health Awareness
America's Diabetes Challenge
Pushing to Outpace Superbugs
The Evolution of Cancer Research
Parasites and Your Pets
Meet Ayesha Sitlani
Every Woman Every Child Event
Everyday Heroes
New Approaches to Fighting Cancer
Insomnia
Advancing Oncology Research Through Clinical Trials
Bridging the Gap  in Diabetes Care
Closing the Circle on Rabies
Desafiando la Diabetes
Understanding Diabetes
Helping Empower Women Living with HIV
Diabetes and Travel
Vaccines: Our History, Our Legacy
The Impact of Cancer
A Point of View by Eric Rubin, M.D.
Making a Difference






Inventing For Life


×
Inventing For Life

Inventing For Life






Products


×
Products

Products
Product List A-Z
Vaccines & Prescribing Information 
Prescription Products & Prescribing Information


Oncology Products & Prescribing Information

Animal Health


Product Patents
Authorized Distributors
Vaccine Contracted Distributors




Research


×
Research

Research
Our People, Our Culture

– The MRL Postdoctoral Research Fellow Program




Our R&D Process
What We're Working On
Pipeline


Clinical Trials
Invent with Us
Discover Where Our Research Happens




Licensing


×
Licensing

Business Development & Licensing


Incyte
Moderna
NGM Biopharmaceuticals



BD&L Contacts


News & Events






Newsroom


×
Newsroom

Newsroom
News Releases

– Prescription Medicine News
– Consumer Care News
– Vaccine News
– Research & Development News
– Corporate News
– Financial News
– Corporate Responsibility News
– Animal Health News





Information Centers


– Diabetes
– Ebola
– Hepatitis C
– Oncology


Company Statements

Media Center


Company Snapshot
Social Media






Careers


×
Careers

Careers
Apply Now
What’s Possible?

My Career Journey @Merck Anna Dickstein
My Career Journey @Merck Fran Murphy
My Career Journey @Merck Paige Cramer




Why Merck?


– Diversity At Merck
– From Service to Science
– Prepared for Launch
– Compensation and Benefits


How Will You Invent the Future?

My Career Journey @Merck Frank Clyburn







Canada
MSD Worldwide




Investors


×
Investors

Investors
Product Pipeline
News
Events & Presentations


Stock Info

– Stock Quote & Chart
– Historical Price Look-up
– Investment Calculator
– Dividend History
– Stock Splits
– Analyst Coverage


Financials

– Quarterly Reports
– Annual Reports & Proxy
– SEC Filings




Governance
Investor Resources

– FAQs
– Stockholder Services
– Corporate Responsibility
– Information Request
– Sign up for Email Alerts
– Other
– Contact Us
















Menu


MENU


















Product List A – Z











                        With a steady focus on innovation and sound science, we work to deliver vaccines, medications, and animal health products that can help millions around the world.
					
The product websites presented here are intended for use in the United States, its territories and Puerto Rico only. Other countries may have different regulatory requirements and review practices that may require referencing different information. If you are a resident of a country other than the United States, please select WORLDWIDE at the top of the page to find information about our offices around the globe. 

Explore our product portfolio:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z



A




ANTIVENIN™ (LATRODECTUS MACTANS)


Prescription
Prescribing Information




ASMANEX®  HFA (mometasone furoate) inhalation aerosol, for oral inhalation use



Prescription
Prescribing Information
Patient Product Information




ASMANEX®  TWISTHALER®  (mometasone furoate inhalation powder)


Prescription
Prescribing Information
Patient Product Information
Product website




AVELOX®  (moxifloxacin hydrochloride) Tablets, film-coated 


Prescription
Prescribing Information
Medication Guide




AVELOX® I.V. (moxifloxacin hydrochloride) Injection, solution for IV use


Prescription
Prescribing Information
Medication Guide






Top

B



BCG Vaccine   (For Percutaneous Use)


Prescribing Information
Instructions for Use




BELSOMRA® (suvorexant) tablets, for oral use, C-IV



Prescribing Information
Medication Guide
Product website




BRIDION® (sugammadex) Injection, for intravenous use


Prescribing Information





Top 

C


CANCIDAS®  (caspofungin acetate) for Injection, for intravenous use


Prescription
Prescribing Information






CELESTONE®  SOLUSPAN®  (betamethasone sodium phosphate and betamethasone acetate)   Injectable Suspension, USP 30 mg/5 mL (6 mg/mL)


Prescribing Information





CLARINEX®  (desloratadine) Tablets and Oral Solution for oral use


Prescription
Prescribing Information
Patient Product Information





CLARINEX-D® 12 HOUR Extended Release Tablets   (desloratadine/pseudoephedrine sulfate) for oral use


Prescription
Prescribing Information
Patient Product Information











COZAAR®  (losartan potassium Tablets) 


Prescription
Prescribing Information
Patient Product Information





CRIXIVAN®  (INDINAVIR SULFATE) CAPSULES


Prescription
Prescribing Information
Patient Product Information




CUBICIN®  (daptomycin for injection) for Intravenous Use


Prescription
Prescribing Information




CUBICIN®  RF (daptomycin for injection), for intravenous use


Prescription
Prescribing Information




CUSHION GRIP® 


Consumer
Product website




Cyclessa® Tablets (desogestrel and ethinyl estradiol USP) Tablets


Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary





Top 

D


Desogen® Tablets   (desogestrel and ethinyl estradiol tablets USP)


Consumer
Prescribing Information
Patient Package Insert
Patient Package Insert Brief Summary




DIFICID®  (fidaxomicin) tablets, for oral use


Prescription
Prescribing Information




DIPROLENE® AF   (augmented betamethasone dipropionate) Cream, 0.05% for topical use


Consumer
Prescribing Information




DIPROLENE® 
									   (augmented betamethasone dipropionate) Lotion, 0.05% for topical use


Consumer
Prescribing Information




DIPROLENE®    (augmented betamethasone dipropionate) Ointment, 0.05% for topical use


Consumer
Prescribing Information





DULERA® (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use


Consumer
Prescribing Information
Medication Guide
Product website





Top 

E


ELOCON® (mometasone furoate) Cream, 0.1% for topical use


Consumer
Prescribing Information




ELOCON® (mometasone furoate) Lotion, 0.1% for topical use


Consumer
Prescribing Information




ELOCON® (mometasone furoate) Ointment, 0.1% for topical use


Consumer
Prescribing Information




EMEND®   (aprepitant) capsules (aprepitant) for oral suspension


Prescription
Prescribing Information
Patient Product Information
Instructions for Use
Product website







EMEND®     (fosaprepitant dimeglumine) for injection, for intravenous use


Prescription
Prescribing Information (5.4 mg EDTA formulation)
Prescribing Information (18.8 mg EDTA formulation)
Patient Product Information





ENTEREG® (alvimopan) capsules, for oral use


Prescription
Prescribing Information





Top 

F


FOLLISTIM®  AQ Cartridge (follitropin beta injection) for subcutaneous use


Prescribing Information
Patient Product Information and Instructions for Use




FOLLISTIM® AQ   (follitropin beta injection) for subcutaneous use or intramuscular use


Prescribing Information
Patient Product Information and Instructions for Use




FORADIL®  AEROLIZER®  (formoterol fumarate inhalation powder) 


Prescription
Prescribing Information
Medication Guide




FOSAMAX®  (alendronate sodium) tablets and oral solution


Prescribing  Information
Medication Guide





FOSAMAX®  PLUS D (alendronate sodium/cholecalciferol) tablets


Prescription
Prescribing Information
Medication Guide







Top 

G


Ganirelix Acetate Injection


Prescription
Prescribing Information




GARDASIL®  [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]


Vaccine
Prescribing Information
Patient Product Information
Product website





GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular   injection


Vaccine
Prescribing Information
Patient Product Information





GRASTEK®  (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use


Prescription
Prescribing Information
Medication Guide
Product website




GUANIDINE HYDROCHLORIDE Tablets


Prescription
Prescribing Information






Top 

H


HYZAAR®  (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS3)


Prescription
Prescribing Information
Patient Product Information






Top 

I



IMPLANON®  (etonogestrel implant), for subdermal use


Prescription
Prescribing Information
Patient Product Information
Patient Consent Form 
Product website




INTEGRILIN®  (eptifibatide) Injection


Prescription
Prescribing Information




INTRON®  (A interferon alfa-2b, recombinant For Injection)


Prescription

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use – Powder for Solution (5 mL diluent)
Instructions for Use – Solution for Injection
Product website




INVANZ®  (ERTAPENEM FOR INJECTION)


Prescription
Prescribing Information
Product website




ISENTRESS®  (raltegravir) film-coated tablets, for oral use
									  ISENTRESS®  HD (raltegravir) film-coated tablets, for oral use
									  ISENTRESS® 	(raltegravir) chewable tablets, for oral use
									  ISENTRESS® (raltegravir) for oral suspension


Prescription
Prescribing Information
Patient Product Information
Instructions for Use
Product website





Top 

J


JANUMET®  (sitagliptin and metformin HCl) tablets


Prescription
Prescribing Information

Medication Guide
Product website





JANUMET® XR  (sitagliptin and metformin HCl extended-release) tablets


Prescribing Information

Medication Guide
Product website





JANUVIA®  (sitagliptin) Tablets


Prescription
Prescribing Information

Medication Guide
Product website






Top 

K



KEYTRUDA® (pembrolizumab) for injection, for intravenous use
                                       KEYTRUDA® (pembrolizumab) injection, for intravenous use


Prescribing Information
Medication Guide
Product website





Top 

L




LOTRISONE®  Cream   (clotrimazole and betamethasone dipropionate)


Consumer
Prescribing Information
Patient Product Information





Top 

M


MAXALT®  (rizatriptan benzoate) tablets for oral use

									   MAXALT-MLT®  (rizatriptan benzoate) orally disintegrating tablets


Prescription
Prescribing Information
Patient Product Information






M-M-R®  II [MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE]


Vaccine
Prescribing Information
Patient Product Information





Top 

N


NASONEX®  (mometasone furoate monohydrate) Nasal Spray, 50 mcg†   †calculated on the anhydrous basis


Prescription
Prescribing Information
Patient Product Information
Product website




NEXPLANON®  (etonogestrel implant) Radiopaque Subdermal Use Only


Prescribing Information
Patient Product Information 
Patient Consent Form 




NITRO-DUR®     (nitroglycerin) Transdermal Infusion System


Prescribing Information
Patient Product Information




NOXAFIL®  (posaconazole) injection, for intravenous use,   delayed-release tablets, for oral use, and oral suspension 


Prescription
Prescribing Information
Patient Product Information





NuvaRing®  (etonogestrel/ethinyl estradiol vaginal ring)


Prescription
Prescribing Information 
Patient Product Information
Instructions for Use
Product website





Top 

O




Top 

P


Liquid Pedvax HIB®  [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)]


Vaccine
Prescribing Information





PEGINTRON®  (peginterferon alfa-2b) injection, for Subcutaneous Use


Prescription
Prescribing Information (1.25 mL diluent)
Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use – Powder for Injection (traditional vial and syringe - 1.25 mL diluent)
Instructions for Use – Powder for Injection (traditional vial and syringe - 5 mL diluent)
Instructions for Use – PegIntron REDIPEN® 







PNEUMOVAX®  23 [pneumococcal vaccine polyvalent] Sterile, Liquid Vaccine for Intramuscular or   Subcutaneous Injection


Vaccine
Prescribing Information
Patient Product Information
Product website




Pregnyl®  (chorionic gonadotropin for injection, USP)


Prescription
Prescribing Information





PRIMAXIN®  I.V. (IMIPENEM AND CILASTATIN FOR INJECTION)


Prescription
Prescribing Information
Instructions for Use




PRINIVIL®  (LISINOPRIL) TABLETS


Prescription
Prescribing Information





PROPECIA®  (finasteride) tablets for oral use


Prescription
Prescribing Information
Patient Product Information





ProQuad®  [Measles, Mumps, Rubella and Varicella Virus Vaccine Live]   Lyophilized preparation for subcutaneous injection


Vaccine
Prescribing Information (NDC 0006-4999-00)


Vaccine
Prescribing Information (NDC 0006-4171-00)




PROSCAR®  (finasteride) Tablets


Prescription
Prescribing Information
Patient Product Information




PROVENTIL®  HFA (albuterol sulfate) Inhalation Aerosol


Prescription
Prescribing Information
Patient Product Information
Product website





Top 

R


RAGWITEK®  (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use


Prescription
Prescribing Information
Medication Guide
Product website




REBETOL® (ribavirin USP) Capsules and Oral Solution


Prescription
Prescribing Information
Medication Guide




RECOMBIVAX HB®  [HEPATITIS B VACCINE (RECOMBINANT)]


Vaccine
Prescribing Information




REMERON®  (mirtazapine) Tablets


Prescription
Prescribing Information
Medication Guide




REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets


Prescription
Prescribing Information
Medication Guide




RENFLEXIS™  (infliximab-abda) for injection, for intravenous use


Prescription
Prescribing Information
Medication Guide





RotaTeq®  [Rotavirus Vaccine, Live, Oral, Pentavalent] Oral Solution


Vaccine
Prescribing Information
Patient Product Information






Top 

S


SINEMET®  (carbidopa-levodopa) Tablets


Prescription
Prescribing Information




SINEMET®  CR (carbidopa-levodopa) Sustained-Release Tablets


Prescription
Prescribing Information




SINGULAIR®  (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules


Prescription
Prescribing Information
Patient Product Information





SIVEXTRO® (tedizolid phosphate) for injection, for intravenous use   SIVEXTRO® (tedizolid phosphate) tablet, for oral use


Prescription
Prescribing Information




STROMECTOL®  (IVERMECTIN) TABLETS


Prescription
Prescribing Information




SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use


Prescription

Prescribing Information (5 mL diluent)
Medication Guide

Instructions for Use (5 mL diluent)





Top 

T


TEMODAR®  (temozolomide) Capsules

Prescription
Prescribing Information
Patient Product Information
Pharmacist Information





TEMODAR®  (temozolomide) for Injection


Prescription
Prescribing Information
Patient Product Information
Pharmacist Information




TICE® BCG BCG LIVE (FOR INTRAVESICAL USE)


Prescription
Prescribing Information







TRUSOPT®  (dorzolamide hydrochloride ophthalmic solution) Sterile Ophthalmic Solution 2%


Prescription
Prescribing Information
Instructions for Use





Top 

V


VAQTA®  [Hepatitis A Vaccine, Inactivated]


Vaccine
Prescribing Information




VARIVAX®  [Varicella Virus Vaccine Live]


Vaccine
Prescribing Information
Patient Product Information




VICTRELIS®  (boceprevir) Capsules for oral use


Vaccine
Prescribing Information 
Medication Guide 




VYTORIN®   (ezetimibe and simvastatin) Tablets


Prescription
Prescribing Information
Patient Product Information
Product website





Top 


Z



ZEMURON®  (rocuronium bromide) injection solution for intravenous use


Prescription
Prescribing Information




ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use


Prescription
Prescribing Information
Patient Product Information
Product website




ZERBAXA™ (ceftolozane and tazobactam) for injection, for intravenous use


Prescription
Prescribing Information




ZETIA®  (ezetimibe) Tablets


Prescription
Prescribing Information
Patient Product Information
Product website




ZINPLAVA™  (bezlotoxumab) injection, for intravenous use


Prescription
Prescribing Information
Patient Product Information




ZOCOR®   (simvastatin) Tablets


Prescription
Prescribing Information





ZOLINZA®  (vorinostat) Capsules


Prescription
Prescribing Information
Patient Product Information






ZONTIVITY®  (vorapaxar) Tablets 2.08 mg*, for oral use *Equivalent to 2.5 mg vorapaxar sulfate


Prescription
Prescribing Information
Medication Guide




ZOSTAVAX®  (Zoster Vaccine Live) Suspension for subcutaneous injection


Vaccine
Prescribing Information
Patient Product Information
Product website





Top 



Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck, its subsidiaries or affiliates, except as noted.






HEALTHCARE PROFESSIONALS

Offers direct access to our professional resources.
Healthcare Professionals website


REPORT ADVERSE EXPERIENCE
To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080


RELATED INFORMATION

Patient Assistance Program
Direct to Consumer Advertising Policy











Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 



Forward-Looking Statement
Privacy
Terms of Use
Site Map







×Close
Forward-Looking Statement


Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA 
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
                
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. 
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). 
No Duty to Update  
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. 








































x
Worldwide


Merck





Canada
United States





MSD
Merck is known as MSD outside the United States and Canada. Clicking on any of the links below will take you to a website intended for those living outside the United States and Canada.






Algeria – French
Argentina – Spanish
Australia – English
Austria – German 
Belgium – Dutch, French, English
Brazil – Portuguese
Bulgaria – Bulgarian
Caribbean – English
Central America – Spanish
Chile – Spanish
China – Simplified Chinese
Colombia – Spanish
Costa Rica – Spanish
Croatia – Croatian
Czech Republic – Czech
Denmark – Danish
Dominican Republic – Dominican
Ecuador – Spanish
Egypt – English
Estonia – Estonian




Finland – Finnish
France – French
Fulford India – English
Germany – German
Greece – Greek
Hong Kong – Chinese, English
Hungary – Hungarian
India – English
Indonesia – English
Ireland – English
Italy – Italian
Japan – Japanese
Latvia – Latvian
Lithuania – Lithuanian
Malaysia – English
Mexico – Spanish
Montenegro – Serbian
Netherlands – Dutch
New Zealand – English
Norway – Norwegian




Peru – Spanish
Philippines – English
Poland – Polish
Portugal – Portuguese
Puerto Rico – Spanish, English
Romania – Romanian, English
Russia – Russian
Saudi Arabia – English
Serbia – Serbian
Singapore – English
Slovakia – Slovak
Slovenia – Slovene
South Africa  – English
South Korea – Korean
Spain – Spanish
Sweden – Swedish
Switzerland – English, French, German
Taiwan – Traditional Chinese
Thailand – Thai, English
Turkey – Turkish
Ukraine – Ukrainian
United Kingdom – English
Venezuela – Spanish
Vietnam – Vietnamese 








Close




















































